Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-10 · accession 0001209191-22-003050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-12 | 2022-01-11 | TVTX | ROTE WILLIAM E. | SVP, R, D | S - Sale | $27.40 | -2,500 | 38.4K | -6% | -$68.5K | |
| 2022-01-12 | 2022-01-10 | TVTX | ROTE WILLIAM E. | SVP, R, D | A - Grant | $0.00 | +5,000 | 40.9K | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-11 | S | D | 2,500 | $27.40 | 38,395 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-10 | A | A | 5,000 | $0.00 | 40,895 | D | — | — | (F2) The reporting person's Form 4 filed August 17, 2021 overstated the number of shares of the Issuer's common stock acquired by the reporting person on May 31, 2021 pursuant to an employee stock purchase program in the amount of 399 shares. The number of shares set forth in column 5 above has been adjusted to correct such overstatement and to include 563 shares of the Issuer's common stock acquired by the reporting person on November 30, 2021 pursuant to an employee stock purchase program. |